TOKYO -- A Japanese court ruled Tuesday in favor of a patent application by a U.S. institute on the breakthrough CRISPR-Cas9 gene-editing technique, in a win for a technology embroiled in intellectual property disputes worldwide.
Biotechnology
CRISPR gene editing wins Japan patent case
Ruling for US lab has potential to raise costs for drug and food development
A technician works with genome samples at a lab of the Chinese biotech company Sinogene, which specializes in dog cloning. © Reuters
Read Next
Latest on Biotechnology
